Patents by Inventor Elissa P. Sena

Elissa P. Sena has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040019916
    Abstract: The invention relates to methods for targeting an exogenous polynucleotide or exogenous complementary polynucleotide pair to a predetermined endogenous DNA target sequence in a eukaryotic cell by homologous pairing, particularly for altering an endogenous DNA sequence, such as a chromosomal DNA sequence, typically by targeted homologous recombination. In certain embodiments, the invention relates to methods for targeting an exogenous polynucleotide having a linked chemical substituent to a predetermined endogenous DNA sequence in a metabolically active eukaryotic cell, generating a DNA sequence-specific targeting of one or more chemical substituents in an intact nucleus of a metabolically active eukaryotic cell, generally for purposes of altering a predetermined endogenous DNA sequence in the cell.
    Type: Application
    Filed: March 3, 2003
    Publication date: January 29, 2004
    Inventors: David A. Zarling, Elissa P. Sena
  • Publication number: 20030105039
    Abstract: The invention relates to methods for targeting an exogenous polynucleotide or exogenous complementary polynucleotide pair to a predetermined endogenous DNA target sequence in a target cell by homologous pairing, particularly for altering an endogenous DNA sequence, such as a chromosomal DNA sequence, typically by targeted homologous recombination. In certain embodiments, the invention relates to methods for targeting an exogenous polynucleotide having a linked chemical substituent to a predetermined endogenous DNA sequence in a metabolically active target cell, generating a DNA sequence-specific targeting of one or more chemical substituents in an intact nucleus of a metabolically active target cell, generally for purposes of altering a predetermined endogenous DNA sequence in the cell.
    Type: Application
    Filed: November 20, 2001
    Publication date: June 5, 2003
    Inventors: David A. Zarling, Elissa P. Sena, Sushma Pati
  • Patent number: 6255113
    Abstract: The invention relates to methods for targeting an exogenous polynucleotide or exogenous complementary polynucleotide pair to a predetermined endogenous DNA target sequence in a eukaryotic cell by homologous pairing, particularly for altering an endogenous DNA sequence, such as a chromosomal DNA sequence, typically by targeted homologous recombination. In certain embodiments, the invention relates to methods for targeting an exogenous polynucleotide having a linked chemical substituent to a predetermined endogenous DNA sequence in a metabolically active eukaryotic cell, generating a DNA sequence-specific targeting of one or more chemical substituents in an intact nucleus of a metabolically active eukaryotic cell, generally for purposes of altering a predetermined endogenous DNA sequence in the cell.
    Type: Grant
    Filed: February 8, 1995
    Date of Patent: July 3, 2001
    Assignee: SRI International
    Inventors: David A. Zarling, Elissa P. Sena
  • Patent number: 5763240
    Abstract: The invention relates to methods for targeting an exogenous polynucleotide or exogenous complementary polynucleotide pair to a predetermined endogenous DNA target sequence in a eukaryotic cell by homologous pairing, particularly for altering an endogenous DNA sequence, such as a chromosomal DNA sequence, typically by targeted homologous recombination. In certain embodiments, the invention relates to methods for targeting an exogenous polynucleotide having a linked chemical substituent to a predetermined endogenous DNA sequence in a metabolically active eukaryotic cell, generating a DNA sequence-specific targeting of one or more chemical substituents in an intact nucleus of a metabolically active eukaryotic cell, generally for purposes of altering a predetermined endogenous DNA sequence in the cell.
    Type: Grant
    Filed: July 14, 1994
    Date of Patent: June 9, 1998
    Assignee: SRI International
    Inventors: David A. Zarling, Elissa P. Sena
  • Patent number: 5719023
    Abstract: A method of identifying the presence of a known target sequence in nucleic acid contained in a fixed cellular or subcellular biological structure. By adding a stable, reporter-labeled RecA/single-stranded probe complex to the cellular or subcellular structure, the target sequence can be effectively labeled by in situ hybridization, allowing the target sequence to be visualized histologically and microscopically or detected by in situ cytometry or cell sorting flow techniques.
    Type: Grant
    Filed: June 3, 1994
    Date of Patent: February 17, 1998
    Assignee: Daikin Industries, Ltd.
    Inventors: David A. Zarling, Cornelia J. Calhoun, Elissa P. Sena
  • Patent number: 5670316
    Abstract: The present invention describes the formation of RecA protein catalyzed double-stranded probe:duplex linear target DNA complexes that are stable to deproteinization. The uses of this stable probe:target complex in diagnostic/DNA detection systems in in vitro and in situ DNA hybridization reactions is discussed. The probe:target complexes are also useful for diagnostic application in RecA protein facilitated DNA amplification reactions.
    Type: Grant
    Filed: May 25, 1994
    Date of Patent: September 23, 1997
    Assignee: Daikin Industries, Ltd.
    Inventors: Elissa P. Sena, Cornelia J. Calhoun, David A. Zarling
  • Patent number: 5506098
    Abstract: A method of identifying the presence of a known target sequence in double-stranded DNA contained in a fixed cellular or subcellular biological structure. By adding a stable, reporter-labeled RecA/single-stranded probe complex to the structure, the target sequence can be effectively labeled by in situ hybridization, allowing the target sequence to be visualized histologically and microscopically or detected by in situ cytometry or cell sorting flow techniques.
    Type: Grant
    Filed: September 4, 1991
    Date of Patent: April 9, 1996
    Assignee: Daikin Industries, Ltd.
    Inventors: David A. Zarling, Cornelia J. Calhoun, Elissa P. Sena
  • Patent number: 5273881
    Abstract: The present invention describes the formation of RecA protein catalyzed double-stranded probe:duplex linear target DNA complexes that are stable to deproteinization. The uses of this stable probe:target complex in diagnostic/DNA detection systems in in vitro and in situ DNA hybridization reactions is discussed. The probe:target complexes are also useful for diagnostic application in RecA protein facilitated DNA amplification reactions.
    Type: Grant
    Filed: September 4, 1991
    Date of Patent: December 28, 1993
    Assignee: Daikin Industries, Ltd.
    Inventors: Elissa P. Sena, Cornelia J. Calhoun, David A. Zarling
  • Patent number: 5223414
    Abstract: The present invention is directed to a method of achieving RecA protein facilitated amplification of a double-stranded DNA target sequence having first and second complementary strands, each strand with 5' and 3' ends. The method involves complexing a primer complementary to a 5' end region of the first strand and a primer complementary to a 5' end region of the second strand with RecA protein in the presence of ATP-.gamma.-S. The complexed primers are then reacted in a mixture also containing the target sequence, all four dNTPs, RecA protein and DNA polymerase. The reaction is conducted below the temperature required for thermal dissociation of the two target strands and continued until a desired degree of amplification of the target sequence is achieved.The present invention further includes the cloning and identification of the coding sequences for the RecA protein of Thermus aquaticus.
    Type: Grant
    Filed: May 7, 1990
    Date of Patent: June 29, 1993
    Assignee: SRI International
    Inventors: David A. Zarling, Elissa P. Sena, Christopher J. Green